Patent Assignment
Reel/Frame 064366/0537
Confirmatory License
Recorded: 2023-07-24
Pages: 2
Assignor
SHIFA BIOMEDICAL CORPORATION
Executed: 2023-06-25
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or Prevention of Cardiovascular Diseases
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 7, 2017
From: ABDEL-MEGUID, SHERIN SALAHELDIN; ELSHOURBAGY, NABIL; MEYERS, HAROLD; MOUSA, SHAKER A.
To: SHIFA BIOMEDICAL CORPORATION
Reel/Frame 041926/0956 →
Confirmatory License
Jul 25, 2023
From: SHIFA BIOMEDICAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064380/0957 →